Who invested in Autolus Therapeutics?
One investor is on record as having backed Autolus Therapeutics — CAR T-cell therapy for cancer and autoimmune diseases, in Biotech. Each row below says whether the round came from the investor's own portfolio page or from the press.
Autolus Therapeutics investors
No round dates are on record for Autolus Therapeutics. A portfolio page names its companies far more often than it dates the cheque, and we would rather leave the field empty than guess it.
The funds that backed Autolus Therapeutics are in the directory.
If they wrote this cheque, they may write yours. Pitch2Fund scores your startup against every one of them, gives you the partner to write to, and drafts the email. Free.